Bright Ideas - CIN Feasibility Study
NCT04929899 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75
Last updated 2025-01-31
Summary
In this study investigators will determine the feasibility of a future trial comparing chemotherapy-induced nausea control in children with ALL receiving oral 6-mercaptopurine who do and do not receive problem-solving skill training. This is a novel approach to controlling an important and common treatment-related symptom.
Conditions
- Acute Lymphoblastic Leukemia (ALL)
Interventions
- BEHAVIORAL
-
Bright Ideas - CIN Training
Bright IDEAS is a validated problem-solving skill training intervention.
Sponsors & Collaborators
-
Rutgers Cancer Institute of New Jersey
collaborator OTHER -
Inova Fairfax Hospital
collaborator OTHER -
Children's Hospital Los Angeles
collaborator OTHER -
The Hospital for Sick Children
lead OTHER
Principal Investigators
-
Lee Dupuis, PhD · SickKids Research Institute
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 4 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-01
- Primary Completion
- 2025-06-30
- Completion
- 2025-06-30
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
NCT00002812 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Acute Lymphoblastic Leukemia in Children
NCT00165178 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
NCT00003783 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
NCT00003671 ·Status: COMPLETED ·Phase: PHASE2
-
N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma
NCT00646230 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study Investigating the Effects of Acetyl-L-Carnitine and Vincristine-Induced Neuropathy in Pediatric Patients With ALL
NCT02598622 ·Status: TERMINATED ·Phase: PHASE2
-
Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With Leukemia
NCT01150669 ·Status: COMPLETED
-
Informed Consent in Pediatric Cancer Trials
NCT00923650 ·Status: COMPLETED
-
A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer
NCT00491946 ·Status: UNKNOWN ·Phase: PHASE4
-
Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
NCT00005585 ·Status: COMPLETED ·Phase: PHASE3
-
Validation Study of Pediatric Patient-Reported Outcomes
NCT03229837 ·Status: COMPLETED
-
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00002744 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy in Treating Children With Recurrent Acute Myeloid Leukemia
NCT00003178 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia
NCT00002704 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia
NCT00019409 ·Status: WITHDRAWN ·Phase: PHASE3
-
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
NCT00002816 ·Status: COMPLETED ·Phase: PHASE3
-
Fenretinide in Treating Children With Solid Tumors
NCT00003191 ·Status: COMPLETED ·Phase: PHASE1
-
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
NCT05999994 ·Status: RECRUITING ·Phase: PHASE2
-
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
NCT02847130 ·Status: COMPLETED
-
Vincristine PK and PD in the AYA Population Compared to Younger Children
NCT02360930 ·Status: UNKNOWN
-
Combination Chemotherapy in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy
NCT00006095 ·Status: COMPLETED ·Phase: PHASE1
-
Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors
NCT00624962 ·Status: WITHDRAWN ·Phase: NA
-
Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
NCT07326930 ·Status: RECRUITING
-
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00557193 ·Status: COMPLETED ·Phase: PHASE3
-
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
NCT00381680 ·Status: COMPLETED ·Phase: PHASE3